ILMN
$327.97
Illumina
$5.88
1.83%
ILMN
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $1.07
Revenue:  $877.89 Mil
Thursday
Jan 28
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ILMN reports earnings?
Beat
Meet
Miss

Where is ILMN's stock price going from here?
Up
Flat
Down
Stock chart of ILMN
Analysts
Summary of analysts' recommendations for ILMN
Score
Grade
Pivots
Resistance
$337.62
$330.08
$326.09

$318.55

Support
$314.56
$307.02
$303.03
Tweet
Growth
Description
Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Peers
Agilent TechnologiesPerkinElmerTranslate BioCoherentBio-Rad LaboratoriesHarvard Bioscience